Pacific Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 5.23 M
- Company Age 41 Year, 7 Months
- Last Filing with ROC 31 Mar 2005
- Open Charges ₹ 2.70 M
About Pacific Pharmaceuticals
Pacific Pharmaceuticals Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 July 1983 and has a history of 41 years and seven months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2005. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.23 M.
The company currently has active open charges totaling ₹2.70 M.
Kenya Shetty and Sujatha Shetty serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230KA1983PTC005410
- Company No.
005410
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 1983
- Date of AGM
30 Sep 2005
- Date of Balance Sheet
31 Mar 2005
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Pacific Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kenya Shetty  | Managing Director | 15-Mar-1985 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujatha Shetty | Director | 04-Feb-1985 | Current |
Financial Performance of Pacific Pharmaceuticals.
Enhance accessibility to Pacific Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pacific Pharmaceuticals?
Unlock access to Pacific Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹2.70 M
₹0
Charges Breakdown by Lending Institutions
- Vijaya Bank : 0.27 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jul 1994 | Vijaya Bank | ₹0.30 M | Open |
| 06 Jul 1993 | Vijaya Bank | ₹2.40 M | Open |
How Many Employees Work at Pacific Pharmaceuticals?
Unlock and access historical data on people associated with Pacific Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pacific Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pacific Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.